Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), María L. García(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Marta Espina(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Marta Barenys(Universitat de Barcelona), Patric Turowski(Institute of Ophthalmology), Miren Ettcheto(Instituto de Salud Carlos III), Britta Anna Kühne(Universitat de Barcelona), Emma Barroso(Hospital Sant Joan de Déu Barcelona), Eliana B. Souto(Universidade do Porto), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Carmen Auladell(Universitat de Barcelona), Jui-Hsien Chang(University College Hospital), Jaume Folch(Biomedical Research Networking Center on Neurodegenerative Diseases)
Cited by 330
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
|International Journal of Pharmaceutics|2004|664
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
|Journal of Nanobiotechnology|2018|284